We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Spinal Fusion Cost-Effectiveness Questioned

By HospiMedica International staff writers
Posted on 14 Jan 2009
A new study suggests that for patients with spinal stenosis with associated slipped vertebrae, the benefits of the fusion procedure are not enough to offset the costs.

Researchers at Dartmouth Medical School (DMS, Hanover, NH, USA) followed 762 patients who participated in the Spine Patient Outcomes Research Trial (SPORT). More...
Of 394 spinal stenosis patients receiving surgery, 320 underwent laminectomy, a procedure that relieves pressure on the nerves through removal of bone and soft tissue. Three hundred forty-four out of 368 surgical patients with stenosis with degenerative spondylolisthesis had spinal fusion. The researchers used the Quality Adjusted Life Year (QALY) scale to measure benefit to patients in comparison to the direct and indirect costs of the surgical procedures.

The study results showed that two years out from surgery, although patients in both groups who had the procedures had better clinical results than those treated non-operatively, the benefits gained in functionality and quality of life were not enough to offset the direct medical costs of fusion, combined with indirect costs such as work-time missed. In contrast, laminectomy for spinal stenosis proved to be effective clinically and economically. The study was published in the December 16, 2008 issue of Annals of Internal Medicine.

"Given the tremendous increase in the number of spinal fusion procedures, the question of cost-effectiveness has critical implications for the health care system,” said lead author Anna Tosteson, M.D., a professor of medicine and community and family medicine at DMS. "This study is significant because it is the first to systematically track people's health care expenditures and health outcomes for these common and costly conditions.”

Lumbar spine fusion, in which two or more vertebrae are permanently joined to decrease spine instability, accounts for more than one third of all back surgeries in the United States. However, while stenosis surgery (usually laminectomy) cost about $77,000 per QALY gained, surgery for stenosis with slipped vertebrae (which usually involves fusion) costs about $115,000 per QALY gained. In contrast, $100,000 is the threshold at which procedures are considered cost-effective In the United States.

Related Links:

Dartmouth Medical School




Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.